BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6288444)

  • 21. Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster.
    Pfeiffer CJ; Chernenko GA; Kohli Y; Barrowman JA
    Can J Physiol Pharmacol; 1982 Mar; 60(3):358-62. PubMed ID: 6176305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of reserpine on the ultrastructure and secretory responses of rat exocrine pancreas.
    Setser ME; Spicer SS; Simson JA; Adamson M; Martinez JR
    Exp Mol Pathol; 1979 Dec; 31(3):413-22. PubMed ID: 228970
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Nov; 75(4):313-6. PubMed ID: 6274669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia.
    Levine AS; Morley JE
    Regul Pept; 1981 Nov; 2(6):353-7. PubMed ID: 6272376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Ann N Y Acad Sci; 1994 Mar; 713():439-41. PubMed ID: 8018216
    [No Abstract]   [Full Text] [Related]  

  • 28. The action of synthetic secretin, cholecystokinin-octapeptide and combinations of these hormones on the secretion of the isolated perfused rat pancreas.
    Sommer H; Kasper H
    Hepatogastroenterology; 1981 Dec; 28(6):311-5. PubMed ID: 6178671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin- and secretin-induced pancreatic secretion in normal and diabetic rats.
    Sofranková A; Dockray GJ
    Am J Physiol; 1983 Apr; 244(4):G370-4. PubMed ID: 6301289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin-octapeptide effects on eating elicited by "external" versus "internal" cues in rats.
    Schallert T; Pendergrass M; Farrar SB
    Appetite; 1982 Jun; 3(2):81-90. PubMed ID: 6291458
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(1):145-8. PubMed ID: 6281503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct modulation of epidermal growth factor binding by cholecystokinin.
    Korc M; Matrisian LM; Magun BE
    Life Sci; 1983 Aug; 33(6):561-8. PubMed ID: 6310297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hydrocortisone on the maturation of cholecystokinin (CCK) binding and CCK stimulated amylase release in pancreatic acini of neonatal rats.
    Leung YK; Jirapinyo P; Lebenthal E; Lee PC
    Pancreas; 1987; 2(1):73-8. PubMed ID: 2437573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
    Stein LJ; Woods SC
    Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hydrocortisone on glucose- and cholecystokinin-induced insulin release from the isolated perfused rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Suehiro I; Nakamura T; Fujii M; Tani S; Baba S
    Pancreas; 1988; 3(4):459-64. PubMed ID: 3050978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat.
    Valenzuela JE; Defilippi C
    Gastroenterology; 1981 Nov; 81(5):898-902. PubMed ID: 6269946
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of sulfated and unsulfated cholecystokinin octapeptide on conditioned feeding behaviour in rats.
    Fekete M; Balázs M; Penke B; Telegdy G
    Peptides; 1981; 2(4):385-8. PubMed ID: 6276866
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Peptides; 1983; 4(1):67-70. PubMed ID: 6306617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.